|Bid||0.00 x 800|
|Ask||0.00 x 1000|
|Day's Range||139.75 - 143.24|
|52 Week Range||120.67 - 308.00|
|Beta (5Y Monthly)||0.31|
|PE Ratio (TTM)||N/A|
|Earnings Date||Oct. 27, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||191.58|
Teladoc Health's (NYSE: TDOC) stock performance this year isn't putting a smile on its investors' faces. The shares have slipped about 30%. That's after a 138% increase last year. Teladoc's online medical visits and revenue soared in 2020 as patients opted for telehealth over in-person appointments.
Cathie Wood is head of Ark Invest, a company managing several funds that are popular with investors. Among these are financial technology company Square (NYSE: SQ), streaming-TV platform Roku (NASDAQ: ROKU), and telehealth services company Teladoc Health (NYSE: TDOC). It might seem like I'm randomly rolling the dice with Square, Roku, and Teladoc, but nothing could be further from the truth.
Teladoc (TDOC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.